Ignite Creation Date:
2025-12-24 @ 10:21 PM
Ignite Modification Date:
2025-12-31 @ 12:58 PM
Study NCT ID:
NCT03259035
Status:
COMPLETED
Last Update Posted:
2024-10-10
First Post:
2017-08-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Organization:
Study Overview
Official Title:
NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to find out the effects of chemotherapy followed by less invasive surgery on patients and their early rectal cancer. The approach of this trial will be considered a success if at least 65% of participants are able to keep the rectum.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: